Q3 2024 Holdings
Filed 2024-11-14 | 55 holdings | $3.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $1.1B | 21,751,284 | 32.1% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $244.3M | 5,161,801 | 7.1% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $157.8M | 3,478,612 | 4.6% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $120.0M | 3,075,907 | 3.5% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $109.6M | 4,661,194 | 3.2% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $109.1M | 9,135,893 | 3.2% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $98.3M | 2,238,986 | 2.9% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $96.3M | 5,750,683 | 2.8% |
| Xoma Royalty Corporation(XOMA) | COM NEW | 98419J206 | $96.2M | 3,633,743 | 2.8% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $94.0M | 1,046,000 | 2.8% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $83.3M | 1,850,167 | 2.4% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $79.8M | 7,382,642 | 2.3% |
| AC Immune SA(ACIU) | SHS | H00263105 | $73.8M | 19,522,436 | 2.2% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $69.6M | 10,400,158 | 2.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $65.9M | 3,371,761 | 1.9% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $59.2M | 4,365,933 | 1.7% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $58.2M | 1,451,879 | 1.7% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $57.8M | 4,607,935 | 1.7% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $53.0M | 8,748,629 | 1.6% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $52.9M | 1,190,107 | 1.5% |
| Celcuity Inc(CELC) | COM | 15102K100 | $51.7M | 3,466,000 | 1.5% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $50.4M | 6,811,631 | 1.5% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $49.4M | 5,302,000 | 1.4% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $45.2M | 1,569,422 | 1.3% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $44.7M | 1,409,993 | 1.3% |
| Annexon Inc(ANNX) | COM | 03589W102 | $41.4M | 7,000,000 | 1.2% |
| CG Oncology Inc(CGON) | COM | 156944100 | $37.5M | 994,596 | 1.1% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $35.5M | 10,333,600 | 1.0% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $25.3M | 1,521,948 | 0.7% |
| Xencor Inc(XNCR) | COM | 98401F105 | $17.1M | 850,000 | 0.5% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $15.7M | 6,293,282 | 0.5% |
| Tscan Therapeutics Inc(TCRX) | COM | 89854M101 | $14.9M | 2,989,474 | 0.4% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $14.9M | 2,251,037 | 0.4% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $14.7M | 8,902,972 | 0.4% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $10.8M | 16,552,417 | 0.3% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $9.1M | 967,000 | 0.3% |
| Ikena Oncology Inc | COM | 45175G108 | $8.3M | 4,769,164 | 0.2% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $7.6M | 703,065 | 0.2% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $6.2M | 5,228,461 | 0.2% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $6.2M | 1,813,633 | 0.2% |
| Vistagen Therapeutics Inc(VTGN) | COM | 92840H400 | $6.0M | 2,000,000 | 0.2% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $5.0M | 1,685,219 | 0.1% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $4.5M | 3,853,818 | 0.1% |
| Pieris Pharmaceuticals Inc | COM NEW | 720795202 | $4.3M | 257,626 | 0.1% |
| Verve Therapeutics Inc | COM | 92539P101 | $3.1M | 650,000 | 0.1% |
| SAB Biotherapeutics Inc(SABS) | COM NEW | 78397T202 | $2.5M | 917,826 | 0.1% |
| Molecular Partners AG(MOLN) | ADS | 60853G106 | $2.1M | 443,221 | 0.1% |
| Elevation Oncology Inc | COM | 28623U101 | $1.8M | 2,966,836 | 0.1% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $1.6M | 9,544,262 | 0.0% |
| Inventiva SA(IVA) | ADS | 46124U107 | $1.3M | 686,040 | 0.0% |